TargED Biopharmaceuticals
Utrecht
About TargED Biopharmaceuticals
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $85.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: targedbiopharmaceuticals.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/targed-biopharmaceuticals-99430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.